MILIND JAVLE to Cell Proliferation
This is a "connection" page, showing publications MILIND JAVLE has written about Cell Proliferation.
Connection Strength
0.312
-
LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy. Oncotarget. 2015 May 10; 6(13):10940-9.
Score: 0.212
-
Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancer. Br J Cancer. 2015 Mar 17; 112(6):1042-51.
Score: 0.052
-
4-1BB Agonist Focuses CD8+ Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic Cancer. Clin Cancer Res. 2017 Dec 01; 23(23):7263-7275.
Score: 0.016
-
Mutational Profiles Reveal an Aberrant TGF-?-CEA Regulated Pathway in Colon Adenomas. PLoS One. 2016; 11(4):e0153933.
Score: 0.014
-
Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma. Oncogene. 2013 Aug 08; 32(32):3722-31.
Score: 0.011
-
Nuclear or cytoplasmic expression of survivin: what is the significance? Int J Cancer. 2005 Apr 20; 114(4):509-12.
Score: 0.007